New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, the expert panel on Saturday gave similar direction for the indigenously developed coronavirus vaccine Covaxin with certain conditions.
Bharat Biotech, which has developed Covaxin in collaboration with Indian Council of Medical Research (ICMR), had applied to the Drugs Controller General Of India (DCGI) seeking emergency use authorisation (EUA) for its Covaxin on December 7.
The expert committee, which had asked for further data on its phase 3 trials, again deliberated on emergency use application of the Hyderabad-based pharma company after they submitted additional data, facts and analysis, The Indian Express reported.
Also Read: Govt Panel Okays Oxford Vaccine In India, DCGI To Take Final Call On Rollout
Also Read: After Pfizer & SII, Bharat Biotech Too Seeks Emergency Use Approval For Covaxin
Also Read: Covaxin Capable Of Dealing With New COVID Strains, Says Bharat Biotech Chairman
Bhubaneswar: The Election Commission of India (ECI) on Thursday ordered the transfer of secretary of…
Mumbai: Everyone in India is a cricket expert and has an opinion on every debatable issue…
Bhubaneswar: The Central leaders of BJP have moved the Election Commission of India (ECI) against…
New Delhi: The process of granting citizenship under the Citizenship (Amendment) Act [CAA] will start…
Bhubaneswar: Social Media monitoring cell of Odisha Police has blocked 292 offensive posts related to…
Baripada: Police have arrested a woman for allegedly killing her husband in Odisha’s Mayurbhanj district.…
Kolkata: In a sensational charge, a female employee of Raj Bhavan has accused West Bengal…
Keonjhar: At least 10 labourers were reportedly injured in an explosion in a steel plant…